Search

everythinglearnresearchcommunity

for

Search:↓

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

miR-155-5p can help diagnose and track alopecia areata severity.

Altered lipid pathways in diabetic women may cause premature greying.

Unhealthy diet and lifestyle choices may increase the risk of hair loss in women.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Higher alarin levels might link hair loss and metabolic syndrome.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Phoenixin levels are higher in PCOS patients and may help in diagnosis.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

People with androgenetic alopecia have a higher risk of heart disease.

Higher cortisol and cortisone levels in hair may predict mood disorders after a stroke.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Sodium metabisulfite increases sodium channel activity, leading to higher cell excitability and potential damage.

Coconut oil reduces hair damage and breakage more effectively than shampoos and conditioners.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

The guidelines suggest reconsidering PCOS criteria for better diagnosis and care.